Inhibrx Biosciences, Inc. (INBX)
Nasdaq: INBX · Biological Products, (No Diagnostic Substances) · La Jolla, CA · filing with the SEC since 2024
Filings
94 filings since 2017 beside 64 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 44 days after the quarter ended. The proxy statement was last filed Apr 23, 2026.
Filings a yearinsider forms included
674150
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Apr 1, 2025.SEC letters: 6 in the last 36 months, the newest Jun 14, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 8, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Jul 16, 2026
8-K items 1.01, 2.03, 3.02, 7.01, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Jul 15, 2026
Jun 15, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
May 11, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Apr 21, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Dec 16, 2025
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Oct 23, 2025
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
40 of 94 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.